Cutaneous Side Effects and Transepidermal Water Loss To Gefitinib: A Study of 11 Patients

Introduction Cutaneous side effects caused by epidermal growth factor receptor (EGFR) inhibitors occurred in 45–100% of patients which may lead to therapy modification or interruption. This study aimed to evaluate cutaneous side effects and transepidermal water loss (TEWL) values in non-small cell l...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Dermatology and therapy 2017-03, Vol.7 (1), p.133-141
Hauptverfasser:	Chandra, Franky, Sandiono, Dendi, Sugiri, Unwati, Suwarsa, Oki, Gunawan, Hendra
Format:	Artikel
Sprache:	eng
Schlagworte:	Complications and side effects Dermatology Dermatotoxicology Dosage and administration Drug therapy Gefitinib Internal Medicine Lung cancer, Non-small cell Medicine Medicine & Public Health Oral and Maxillofacial Surgery Original Research Plastic Surgery Quality of Life Research Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!